[go: up one dir, main page]

DE60133896D1 - Regulierung einer humanen transmembran-serinprotease - Google Patents

Regulierung einer humanen transmembran-serinprotease

Info

Publication number
DE60133896D1
DE60133896D1 DE60133896T DE60133896T DE60133896D1 DE 60133896 D1 DE60133896 D1 DE 60133896D1 DE 60133896 T DE60133896 T DE 60133896T DE 60133896 T DE60133896 T DE 60133896T DE 60133896 D1 DE60133896 D1 DE 60133896D1
Authority
DE
Germany
Prior art keywords
serine protease
transmembrane serine
human transmembrane
regulating
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133896T
Other languages
English (en)
Inventor
Yonghong Xiao
Richard Gedrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Application granted granted Critical
Publication of DE60133896D1 publication Critical patent/DE60133896D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60133896T 2000-06-13 2001-06-12 Regulierung einer humanen transmembran-serinprotease Expired - Lifetime DE60133896D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21122400P 2000-06-13 2000-06-13
US28335301P 2001-04-13 2001-04-13
US28364801P 2001-04-16 2001-04-16
PCT/EP2001/006618 WO2001096538A2 (en) 2000-06-13 2001-06-12 Regulation of human transmembrane serine protease

Publications (1)

Publication Number Publication Date
DE60133896D1 true DE60133896D1 (de) 2008-06-19

Family

ID=27395612

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133896T Expired - Lifetime DE60133896D1 (de) 2000-06-13 2001-06-12 Regulierung einer humanen transmembran-serinprotease

Country Status (7)

Country Link
US (4) US6734006B2 (de)
EP (1) EP1294903B1 (de)
AT (1) ATE394491T1 (de)
AU (1) AU2001276361A1 (de)
DE (1) DE60133896D1 (de)
ES (1) ES2305093T3 (de)
WO (1) WO2001096538A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
CA2335107C (en) * 1998-07-28 2010-01-19 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Leptin-mediated gene-induction
EP1283878B1 (de) * 2000-05-22 2005-07-27 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Auf rezeptorgrundlage arbeitende screening-verfahren für protein wechselwirkungen
US7235629B2 (en) * 2000-11-14 2007-06-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Functional fragment of the leptin receptor
AU2002310492A1 (en) * 2001-06-20 2003-01-08 Immunex Corporation Dendritic cell transmembrane serine protease
EP1585512A1 (de) * 2003-01-10 2005-10-19 Universiteit van Maastricht Zusammensetzungen und verfahren zurverbesserung des zustands von patienten mit copd und anderen erkrankungen
WO2004098487A2 (en) * 2003-05-05 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5)
CA2535859A1 (en) * 2003-08-14 2005-03-03 Dyax Corp. Endotheliase-2 ligands
EP1678317A2 (de) * 2003-10-17 2006-07-12 Bayer HealthCare AG Diagnostika und therapeutika für krankheiten, die mit dem mosaic serine protease (msp) assoziiert sind
US7553810B2 (en) * 2004-06-16 2009-06-30 Pneumrx, Inc. Lung volume reduction using glue composition
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
US20050281740A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue
US7678767B2 (en) 2004-06-16 2010-03-16 Pneumrx, Inc. Glue compositions for lung volume reduction
US7608579B2 (en) * 2004-06-16 2009-10-27 Pneumrx, Inc. Lung volume reduction using glue compositions
US20050281739A1 (en) * 2004-06-16 2005-12-22 Glen Gong Imaging damaged lung tissue using compositions
US20050281798A1 (en) * 2004-06-16 2005-12-22 Glen Gong Targeting sites of damaged lung tissue using composition
CA2570261C (en) 2004-07-08 2014-06-10 Pneumrx, Inc. Pleural effusion treatment device, method and material
WO2006053883A1 (en) * 2004-11-18 2006-05-26 Vib Vzw Fibronectin iii domain as leptin receptor antagonists
EP2064300A4 (de) * 2006-09-20 2013-05-22 Pneumrx Inc Gewebehaftzusammensetzungen und verfahren dafür
EP2738198A1 (de) 2012-11-29 2014-06-04 Henkel AG & Co. KGaA Enzymatische Polyamidsynthese in wässriger Miniemulsion
KR101693243B1 (ko) * 2016-06-15 2017-01-05 재단법인 한국파스퇴르연구소 인플루엔자 바이러스의 복제에 관여하는 신규 인간 유전자 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925521A (en) * 1997-03-31 1999-07-20 Incyte Pharmaceuticals, Inc. Human serine carboxypeptidase
DE69943020D1 (de) * 1998-06-01 2011-01-20 Agensys Inc Tumorantigen verwendbar in der diagnose und therapie von prostata und dickdarm-krebs
EP1084259B1 (de) * 1998-06-05 2008-05-28 Bayer Schering Pharma Aktiengesellschaft Corin, eine serinprotease
AU4839999A (en) * 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
CA2391908A1 (en) * 1999-11-17 2001-05-25 Curagen Corporation Novel polypeptides and nucleic acids encoding same
IL149340A0 (en) * 1999-11-18 2002-11-10 Corvas Int Inc Nucleic acids encoding endotheliases, endotheliases and uses thereof

Also Published As

Publication number Publication date
US7622292B2 (en) 2009-11-24
AU2001276361A1 (en) 2001-12-24
EP1294903B1 (de) 2008-05-07
US6734006B2 (en) 2004-05-11
US20020061850A1 (en) 2002-05-23
EP1294903A2 (de) 2003-03-26
US20100069615A1 (en) 2010-03-18
US20040209327A1 (en) 2004-10-21
ES2305093T3 (es) 2008-11-01
ATE394491T1 (de) 2008-05-15
US7314730B2 (en) 2008-01-01
US20090182121A1 (en) 2009-07-16
WO2001096538A2 (en) 2001-12-20
WO2001096538A3 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
DE60133896D1 (de) Regulierung einer humanen transmembran-serinprotease
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
DE10393306D2 (de) Mesenchymale Stammzellen des Haarfollikels und deren Verwendung
PT1202743E (pt) Composicoes farmaceuticas e cosmeticas compreendendo serina-proteases de bacalhau e sua utilizacao farmaceutica e cosmetica
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
MY137828A (en) Keratinocytes which may be used as a biologically active substances for the treatment of wounds
ATE182137T1 (de) Peptidylderivate als inhibitoren von metalloproteinase
WO2022246251A3 (en) Compounds for modulating unc13a expression
NO20022318D0 (no) Nye forbindelser
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
DE60115602D1 (de) Verwendung von säurestabilen subtilisinproteasen in tierfutter
TR199800818A2 (xx) �kame edilmi� diaminokarbonik asitler.
WO2001087958A3 (en) CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
FI980604A0 (fi) Nya matrismetalloproteinasinhibitorer och -regulatorer
WO2001096378A3 (en) Human epithin-like serine protease
DE60034879D1 (en) Lantibiotikum
AU2672099A (en) Compositions and methods for wound healing
DE50304970D1 (de) Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DK1411971T3 (da) Anvendelse af lang gentraxin PTX3 til behandling af kvindelig sterilitet
ATE317399T1 (de) Regulierung der menschlichen prostasin-änhlichen serine protease
EP1660620A4 (de) Verfahren zur verminderung von irritationen bei körperpflegemitteln
WO2001098340A3 (en) Regulation of human mast cell protease 6-like enzyme
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
WO2002000702A3 (en) Regulation of human epidermis-specific serine protease
DE69931784D1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE